«Непонятный» кашель

Кашель – одна из серьезных проблем практической пульмонологии. Механизмы возникновения кашля разнообразны, а заболевания, протекающие с хроническим кашлевым синдромом, многочисленны. Сложна диагностическая ситуация, связанная с «непонятным», «необъяснимым», «идиопатическим» кашлем.

Целью настоящего обзора явилось рассмотрение основных механизмов формирования «непонятного» кашля, вариантов течения, алгоритма ведения пациентов с трудноизлечимым кашлем, а также новых методов лечения.

Заключение. Хронический «непонятный» кашель нарушает качество жизни пациентов, снижает их работоспособность. Знание механизмов его возникновения, способствует повышению эффективности терапии.

1. Чучалин А.Г., Абросимов В.Н. Кашель. М.: ГЭОТАР-Медиа; 2016. Доступно на: https://www.rosmedlib.ru/book/ISBN9785970437285.html [Дата обращения: 04.10.23].

2. Зайцев А.А. Кашель: проблемы и решения. Практическая пульмонология. 2020; (2): 78–86. Доступно на: https://cyberleninka.ru/article/n/kashel-problemy-i-resheniya [Дата обращения: 04.10.23].

3. On P.C. Overview of chronic cough. Am. J. Manag. Care. 2022; 28 (9, Suppl.): S152–158. DOI: 10.37765/ajmc.2022.89243.

4. Schellenberg M., Herth F.J.F. Chronic cough. Inn. Med. (Heidelb.). 2023; 64 (3): 288–294. DOI: 10.1007/s00108-022-01467-w.

5. Шустова С.А., Мирошкина Т.А. Защитные механизмы легких. Российский медико-биологический вестник имени академика И.П.Павлова. 2020; 28 (4): 567–577. DOI: 10.23888/PAVLOVJ2020284567-577.

6. Косяков А. В. Комплексный подход к оценке функционального статуса пациентов с хронической обструктивной болезнью легких. Наука молодых (Eruditio Juvenium). 2021; 9 (4): 553–558. DOI: 10.23888/HMJ202194553-558.

7. Зайцев А.А. Кашель: по страницам международных рекомендаций. Эффективная фармакотерапия. 2019; 15 (27):38–48. DOI: 10.33978/2307-3586-2019-15-27-38-48.

8. Зайцев А.А., Оковитый С.В., Мирошниченко Н.А. и др. Кашель: методические рекомендации для врачей. М.; 2021. Доступно на: https://www.researchgate.net/publication/354162540_Kasel_Metodiceskie_rekomendacii_dla_vracej_Cough_Guidelines_for_physicians [Дата обращения: 04.10.23].

9. Орлова Н.В. Хронический кашель: дифференциальная диагностика и лечение. Медицинский совет. 2020; (17): 124–131. DOI: 10.21518/2079-701X-2020-17-124-131.

10. Зайцев А.А., Оковитый С.В. Кашель: от основ к фармакотерапии. Consilium Medicum. 2020; 22 (11): 72–77. DOI: 10.26442/20751753.2020.11.200523.

11. Lee J.H., Kang S.Y., Yoo Y. et al. Epidemiology of adult chronic cough: disease burden, regional issues, and recent findings. Asia Pac. Allergy. 2021; 11 (4): e38. DOI: 10.5415/apallergy.2021.11.e38.

12. Liang H., Ye W., Wang Z. et al. Prevalence of chronic cough in China: a systematic review and meta-analysis. BMC Pulm. Med. 2022; 22 (1): 62. DOI: 10.1186/s12890-022-01847-w.

13. van den Berg J.W.K., Baxter C.A, Edens M.A. et al. The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands. ERJ Open Res. 2022; 12; 8 (4): 00232-2022. DOI: 10.1183/23120541.00232-2022.

14. Bali V., Weaver J., Turzhitsky V. et al. Development of a natural language processing algorithm to detect chronic cough in electronic health records. BMC Pulm. Med. 2022; 28; 22 (1): 256. DOI: 10.1186/s12890-022-02035-6.

15. Domínguez-Ortega J., Plaza V., Li V.W. et al. Prevalence of chronic cough and patient characteristics in adults in Spain: a population-based cross-sectional survey. Chron. Respir. Dis. 2022; 19: 14799731221098722. DOI: 10.1177/14799731221098722.

16. Tobe K., Kubo T., Okuyama K. et al. Web-based survey to evaluate the prevalence of chronic and subacute cough and patient characteristics in Japan. BMJ Open Respir. Res. 2021; 8 (1): e000832. DOI: 10.1136/bmjresp-2020-000832.

17. Kang J., Moon J.Y., Kim D.K. et al. Cough characteristics and their association patterns according to cough etiology: a network analysis. J. Clin. Med. 2023; 12 (16): 5383. DOI: 10.3390/jcm12165383.

18. Lai K., Peng W., Zhan W. et al. Clinical characteristics in adult patients with somatic cough syndrome. Ther. Adv. Respir. Dis. 2022; 16: 17534666221092993. DOI: 10.1177/17534666221092993.

19. Spanevello A., Beghé B., Visca D. et al. Chronic cough in adults. Eur. J. Intern. Med. 2020; 78: 8–16. DOI: 10.1016/j.ejim.2020.03.018.

20. Krüger K., Holzinger F., Trauth J. et al. Chronic cough. Dtsch. Arztebl. Int. 2022; 119 (5): 59–65. DOI: 10.3238/arztebl.m2021.0396.

21. Good J.T. Jr, Rollins D.R., Kolakowski C.A. et al. New insights in the diagnosis of chronic refractory cough. Respir. Med. 2018; 141: 103–110. DOI: 10.1016/j.rmed.2018.06.024.

22. Chang Y.H., Wang S.R., Huang K.W. [Complications of chronic cough]. Zhonghua Jie He He Hu Xi Za Zhi. 2022; 45 (1): 10–12. DOI: 10.3760/cma.j.cn112147-20211105-00776 (in Chinese).

23. Gibson P.G. Chronic cough. J. Allergy Clin. Immunol. Pract. 2019; 7 (6): 1762. DOI: 10.1016/j.jaip.2019.05.012.

24. Gibson P., Wang G., McGarvey L. et al. Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest. 2016; 149 (1): 27–44. DOI: 10.1378/chest.15-1496.

25. Chung K.F., McGarvey L., Song W.J. et al. Cough hypersensitivity and chronic cough. Nat. Rev. Dis. Primers. 2022; 8 (1): 45. DOI: 10.1038/s41572-022-00370-w.

26. Sacre-Hazouri J.A., Sacre L. Chronic cough. Cough reflex hypersensitivity syndrome. Rev. Alerg. Mex. 2019; 66 (2): 217–231. DOI: 10.29262/ram.v66i2.565.

27. Capristo C., Rossi G.A. Post-infectious persistent cough: pathogenesis and therapeutic options. Minerva Pediatr. 2017; 69 (5): 444–452. DOI: 10.23736/S0026-4946.17.04958-1.

28. Чикина С.Ю. Синдром кашлевой гиперчувствительности. Пульмонология. 2015; 25 (2): 224–228. DOI: 10.18093/0869-0189-2015-25-2-224-228.

29. Sundar K.M., Stark A.C., Hu N. et al. Is laryngeal hypersensitivity the basis of unexplained or refractory chronic cough? ERJ Open Res. 2021; 7 (1): 00793-2020. DOI: 10.1183/23120541.00793-2020.

30. Gouveia C.J., Yalamanchili A., Ghadersohi S. et al. Are chronic cough and laryngopharyngeal reflux more common in obstructive sleep apnea patients? Laryngoscope. 2019; 129 (5): 1244–1249. DOI: 10.1002/lary.27557.

31. Weinberger M. Chronic cough is complicated. Ann. Allergy Asthma Immunol. 2023; 131 (2): 275. DOI: 10.1016/j.anai.2023.03.035.

32. Song W.J., An J., McGarvey L. Recent progress in the management of chronic cough. Korean J. Intern. Med. 2020; 35 (4): 811–822. DOI: 10.3904/kjim.2020.013.

33. Morice A.H., Millqvist E., Bieksiene K. et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur. Respir. J. 2020; 55 (1): 1901136. 10.1183/13993003.01136-2019.

34. Song W.J., Won H.K., An J. et al. Chronic cough in the elderly. Pulm. Pharmacol. Ther. 2019; 56: 63–68. DOI: 10.1016/j.pupt.2019.03.010.

35. De Vincentis A., Baldi F., Calderazzo M. et al. Chronic cough in adults: recommendations from an Italian intersociety consensus. Aging Clin. Exp. Res. 2022; 34 (7): 1529–1550. DOI: 10.1007/s40520-022-02154-4.

36. Mathur A., Liu-Shiu-Cheong P.S.K., Munro A. et al. Chronic cough: a practical approach to assessment and management. Drug Ther. Bull. 2019; 57 (5): 74–79. DOI: 10.1136/dtb.2018.000014.

37. Davis J.A., Gudi K. Approach to the patient with cough. Med. Clin. North Am. 2021; 105 (1): 31–38. DOI: 10.1016/j.mcna.2020.08.013.

38. Almis B.H. [An interesting model for functional neurological disorders: integrative approach to psychogenic dysphonia]. Psikiyatride Güncel Yaklaşımlar. 2022; 14 (3): 353–357. DOI: 10.18863/ pgy.1018579 (in Turkish).

39. Овчаренко С.И., Трошина Д.В., Соколова П.С. и др. Психосоматические функциональные расстройства в пульмонологической практике. Пульмонология. 2023; 33 (3): 386–392. DOI: 10.18093/0869-0189-2023-33-3-386-392.

40. Weinberger M., Lockshin B. When is cough functional, and how should it be treated? Breathe (Sheff.). 2017; 13 (1): 22–30. DOI: 10.1183/20734735.015216.

41. Bai H., Sha B., Xu X., Yu L. Gender difference in chronic cough: are women more likely to cough? Front Physiol. 2021; 12: 654797. DOI: 10.3389/fphys.2021.654797.

42. Ziller V., Oppermann T.S., Cassel W. et al. Chronic cough in postmenopausal women and its associations to climacteric symptoms. BMC Womens Health. 2023; 8; 23 (1): 93. DOI: 10.1186/s12905-023-02225-2.

43. Lai R., Huang L., Zhao H. et al. A multicenter survey on the current status of chronic cough and its impact on quality of life in Guangdong, China. J. Thorac. Dis. 2022; 14 (9): 3624–3632. DOI: 10.21037/jtd-21-1737.

44. Lai K., Long L. Current status and future directions of chronic cough in China. Lung. 2020; 198 (1): 23–29. DOI: 10.1007/s00408-019-00319-z.

45. Wang C., Xia Q., Hu B. et al. The effectiveness and safety of Huangqi Xixin decoction for cough variant asthma: a systematic review and meta-analysis. Evid. Based Complement. Alternat. Med. 2022; 2022: 9492100. DOI: 10.1155/2022/9492100.

46. Huang K., Gu X., Yang T. et al. Prevalence and burden of chronic cough in China: a national cross-sectional study. ERJ Open Res. 2022; 8 (3): 00075-2022. DOI: 10.1183/23120541.00075-2022.

47. Liang H., Ye W., Wang Z. et al. Prevalence of chronic cough in China: a systematic review and meta-analysis. BMC Pulm. Med. 2022; 22 (1): 62. DOI: 10.1186/s12890-022-01847-w.

48. Domingo C., Fernandez M., Garin N. et al. Determining what represents value in the treatment of refractory or unexplained chronic cough from the perspective of key stakeholders in Spain using multi-criteria decision analysis. Appl. Health Econ. Health Policy. 2023; 21 (1): 119–130. DOI: 10.1007/s40258-022-00770-9.

49. Morice A., Dicpinigaitis P., McGarvey L. et al. Chronic cough: new insights and future prospects. Eur. Respir. Rev. 2021; 30 (162): 210127. DOI: 10.1183/16000617.0127-2021.

50. Xie S., Xie M., Shen Y., Cheng D. Gabapentin for chronic refractory cough: a system review and meta-analysis. Heliyon. 2023; 18; 9 (5): e15579. DOI: 10.1016/j.heliyon.2023.e15579.

51. Mazzone S.B., McGarvey L. Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough. Clin. Pharmacol. Ther. 2021; 109 (3): 619–636. DOI: 10.1002/cpt.2003.

52. Morice A.H., Birring S.S., Smith J.A. et al. Characterization of patients with refractory or unexplained chronic cough participating in a phase 2 clinical trial of the P2X3-receptor antagonist gefapixant. Lung. 2021; 199 (2): 121–129. DOI: 10.1007/s00408-021-00437-7.

53. Slinger C., Mehdi Syed B., Stephen J. M. et al. Speech and language therapy for management of chronic cough. Cochrane Database Syst. Rev. 2019; 23; 7 (7): CD013067. DOI: 10.1002/14651858.CD013067.pub2.

54. Zhao K., Bai X., Wen S. et al. Similarities and differences between the cough suppression test and the cough challenge test. Ther. Adv. Respir. Dis. 2023; 17: 17534666231162246. DOI: 10.1177/17534666231162246.

55. Nguyen A.M., Bacci E.D., Vernon M. et al. Validation of a visual analog scale for assessing cough severity in patients with chronic cough. Ther. Adv. Respir. Dis. 2021; 15: 17534666211049743. DOI: 10.1177/17534666211049743.